SSRIs contraindicated in paediatric MDD

被引:0
|
作者
机构
关键词
Major Depressive Disorder; Fluoxetine; Paroxetine; Obsessive Compulsive Disorder; Sertraline;
D O I
10.2165/00128415-200309820-00002
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [21] Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose
    Isbister, GK
    Bowe, SJ
    Dawson, A
    Whyte, IM
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2004, 42 (03): : 277 - 285
  • [25] Impact of ACE2 genetic variant on antidepressant efficacy of SSRIs
    Firouzabadi, Negar
    Farshadfar, Parisa
    Haghnegahdar, Maral
    Alavi-Shoushtari, Ali
    Ghanbarinejad, Vahid
    ACTA NEUROPSYCHIATRICA, 2022, 34 (01): : 30 - 36
  • [26] Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
    Illi, Ari
    Poutanen, Outi
    Setala-Soikkeli, Eija
    Kampman, Olli
    Viikki, Merja
    Huhtala, Heini
    Mononen, Nina
    Haraldsson, Susann
    Koivisto, Pasi A.
    Leinonen, Esa
    Lehtimaki, Terho
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2011, 261 (02) : 95 - 102
  • [27] Selective Serotonin Reuptake Inhibitors (SSRIs) and Hyperprolactinemia: Analysis of the French Pharmacovigilance Database
    Oger, F.
    Buire, A. C.
    Trenque, T.
    DRUG SAFETY, 2008, 31 (10) : 932 - 932
  • [29] Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors
    Rozzini, Luca
    Chilovi, Barbara Vicini
    Conti, Marta
    Bertoletti, Erik
    Zanetti, Marina
    Trabucchi, Marco
    Padovani, Alessandro
    INTERNATIONAL PSYCHOGERIATRICS, 2010, 22 (01) : 114 - 119
  • [30] Selective serotonin Reuptake Inhibitors (SSRIs) and Hyperprolactinemia: Analysis of the French Pharmacovigilance Database
    F. Oger
    A. C. Buire
    T. Trenque
    Drug Safety, 2008, 31 : 885 - 885